Pidacmeran Uses, Dosage, Side Effects and more
Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
| Attribute | Details |
|---|---|
| Trade Name | Pidacmeran |
| Generic | Pidacmeran |
| Pidacmeran Other Names | Pidacmeran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
